IntroductionThe respiratory drugs market refers to the segment of the pharmaceutical industry that deals with drugs designed to treat respiratory disorders, including asthma, chronic obstructive ...

Total net revenue of $76.3 million from Q1 2025 driven by Ohtuvayre® net sales of $71.3 million (+95% vs Q4 2024) ~25,000 ...

Verona Pharma’s Ohtuvayre generated $71.3M in Q1'25 sales, signaling blockbuster potential. Read more on VRNA’s upcoming ...

The Ochsner Transplant Institute in New Orleans stands as a national leader in organ transplant surgery. Since 1984, ...

For further information, please contact Professor Dr Felix Ringshausen, [email protected], telephone (0511) 532-3595. The original paper ‘Phase 3 Trial of the DPP1 Inhibitor Brensocatib ...

Total net revenue of $76.3 million from Q1 2025 driven by Ohtuvayre® net sales of $71.3 million (+95% vs Q4 2024) ~25,000 prescriptions filled in Q1 2025 Q1 2025 revenue exceeds operating expenses exc ...

Cystic Fibrosis Damages the Immune System Early on ... chronic obstructive pulmonary disease (COPD), and ... How a New Gut Microbe Drives the Gut-Lung Axis Dec. 19, 2024 — A team has discovered ...

Q1 2025 Earnings Call Transcript April 29, 2025 Regeneron Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS ...

The European Medicines Agency has recommended marketing approval for Alyftrek for cystic fibrosis and Attrogy for a form of ...

The comprehensive study, which tracked data spanning 20 years, revealed that not only does pregnancy not negatively impact ...

New guidelines for cystic fibrosis screening in newborns improve sensitivity, equity, and timeliness of diagnosis.

Several people have been credited with uttering famous sayings linking the words “living” and “giving,” but Steve Pelican ...